Efficacy and Safety of the KPCXM18 Injection in Patients With Acute Ischemic Stroke

Study acronym: KPCXM18
StatusRecruiting
PhasePhase 2
Started

Record status This record was last updated December 12, 2025 (before its estimated October 18, 2026 completion). Its status may not reflect the trial's current state.

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This study is a multicenter, randomized, double-blind, parallel, placebo-controlled trial design to evaluate the efficacy and safety of the KPCXM18 injection at different doses for the treatment of acute ischemic stroke.
Trial Details
NCT Number NCT07279493
Lead Sponsor Kunming Pharmaceuticals, Inc.
Conditions
(from sponsor)		 Acute Ischemic Stroke
Related terms Ischemic Stroke
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov